AI English summary of an SEC filing — figures as filed

The company said revenue for Q2 2025 (ended June 30) rose to $5.0 billion, up 3% on a reported basis and 2% on an Organic basis. Net income margin was 9.7%, versus 8.9% a year earlier, up 80 basis points.

8-KResults of Operations and Financial ConditionFiled Jul 30, 2025Period of report Jul 30, 2025Summary published (UTC) Oct 8, 2026

Key points

AI summary

The company said revenue for Q2 2025 (ended June 30) rose to $5.0 billion, up 3% on a reported basis and 2% on an Organic basis. Net income margin was 9.7%, versus 8.9% a year earlier, up 80 basis points.
GE HealthCare said Adjusted EBIT for Q2 was $729 million (versus $742 million a year earlier), and Adjusted EBIT margin was 14.6% (versus 15.3%). The company cited tariffs as weighing on the margin, partially offset by benefits from productivity and volume.
The company said cash flow from operating activities improved to $94 million for Q2, from $(119) million a year earlier, and free cash flow was $7 million, compared with $(182) million a year earlier.
The company said it set its 2025 full-year Adjusted EPS outlook at $4.43 to $4.63, adjusted from its prior outlook of $3.90 to $4.10. It said free cash flow is now expected to be at least $1.4 billion, versus at least $1.2 billion previously.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Q2 Revenue $5.0 billion, Net Income Margin 9.7%

The company said revenue for Q2 2025 (ended June 30) rose to $5.0 billion, up 3% on a reported basis and 2% on an Organic basis. Net income margin was 9.7%, versus 8.9% a year earlier, up 80 basis points.

Source · Based on the filing body and exhibits

Q2 Adjusted EBIT $729 million, Margin 14.6%

GE HealthCare said Adjusted EBIT for Q2 was $729 million (versus $742 million a year earlier), and Adjusted EBIT margin was 14.6% (versus 15.3%). The company cited tariffs as weighing on the margin, partially offset by benefits from productivity and volume.

Source · Based on the filing body and exhibits

Q2 Operating Cash Flow $94 million, Free Cash Flow $7 million

The company said cash flow from operating activities improved to $94 million for Q2, from $(119) million a year earlier, and free cash flow was $7 million, compared with $(182) million a year earlier.

Source · Based on the filing body and exhibits

Raises 2025 Full-Year Outlook

The company said it set its 2025 full-year Adjusted EPS outlook at $4.43 to $4.63, adjusted from its prior outlook of $3.90 to $4.10. It said free cash flow is now expected to be at least $1.4 billion, versus at least $1.2 billion previously.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.